Cargando…
Thymidylate Synthase Overexpression Drives the Invasive Phenotype in Colon Cancer Cells
Thymidylate synthase (TYMS) is the crucial enzymatic precursor for DNA biosynthesis and, therefore, the critical target for numerous types of chemotherapy, including the most frequently applied agent in colon cancer treatment 5-fluorouracil (5-FU). TYMS also seems to be associated with cancer metast...
Autores principales: | Ciszewski, Wojciech M., Chmielewska-Kassassir, Małgorzata, Wozniak, Lucyna A., Sobierajska, Katarzyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9219882/ https://www.ncbi.nlm.nih.gov/pubmed/35740289 http://dx.doi.org/10.3390/biomedicines10061267 |
Ejemplares similares
-
Evening Primrose Extract Modulates TYMS Expression via SP1 Transcription Factor in Malignant Pleural Mesothelioma
por: Chmielewska-Kassassir, Małgorzata, et al.
Publicado: (2023) -
Polyphenol Extract from Evening Primrose (Oenothera paradoxa) Inhibits Invasion Properties of Human Malignant Pleural Mesothelioma Cells
por: Chmielewska-Kassassir, Malgorzata, et al.
Publicado: (2020) -
Phytochemicals in Malignant Pleural Mesothelioma Treatment—Review on the Current Trends of Therapies
por: Chmielewska-Kassassir, Malgorzata, et al.
Publicado: (2021) -
Thymidylate synthase drives the phenotypes of epithelial-to-mesenchymal transition in non-small cell lung cancer
por: Siddiqui, Mohammad Aarif, et al.
Publicado: (2020) -
Lactate drives cellular DNA repair capacity: Role of lactate and related short-chain fatty acids in cervical cancer chemoresistance and viral infection
por: Ciszewski, Wojciech M., et al.
Publicado: (2022)